Efficacy of Aprepitant (Emend) in Children Receiving Highly Emetogenic Chemotherapy
Latest Information Update: 24 Mar 2021
At a glance
- Drugs Aprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 06 Mar 2020 Status changed from active, no longer recruiting to completed.
- 22 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 22 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.